Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 26, 2012
Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome
Olivier Trédan, Manuarii Manuel, Gilles Clapisson, et al.
Science Advances
|
January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
Paola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Bulletin Du Cancer
|
December 18, 2022
[A 2022 inventory in oncology news]
Jacques-Olivier Bay, Carole Bouleuc, Christophe Caux, et al.
Oncoimmunology
|
May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage
Colette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
Nature Communications
|
July 3, 2025
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
Valentin Picant, Lara Revol-Bauz, Laurie Tonon, et al.
Cancer Research
|
October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells
Julien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes
Angèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.
Cancer Research
|
June 1, 2013
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment
Isabelle Le Mercier, Dominique Poujol, Amélien Sanlaville, et al.
Cancer Research
|
June 2, 2016
Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy
Kieu-Suong Le, Marie-Laure Thibult, Sylvain Just-Landi, et al.
BMC Cancer
|
July 5, 2020
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial
Lidia Delrieu, Amélie Anota, Olivier Trédan, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
European Journal of Cancer (Oxford, England : 1990)
|
December 26, 2012
Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome
Olivier Trédan, Manuarii Manuel, Gilles Clapisson, et al.
Science Advances
|
January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
Paola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Bulletin Du Cancer
|
December 18, 2022
[A 2022 inventory in oncology news]
Jacques-Olivier Bay, Carole Bouleuc, Christophe Caux, et al.
Oncoimmunology
|
May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage
Colette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
Nature Communications
|
July 3, 2025
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
Valentin Picant, Lara Revol-Bauz, Laurie Tonon, et al.
Cancer Research
|
October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells
Julien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes
Angèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.
Cancer Research
|
June 1, 2013
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment
Isabelle Le Mercier, Dominique Poujol, Amélien Sanlaville, et al.
Cancer Research
|
June 2, 2016
Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy
Kieu-Suong Le, Marie-Laure Thibult, Sylvain Just-Landi, et al.
BMC Cancer
|
July 5, 2020
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial
Lidia Delrieu, Amélie Anota, Olivier Trédan, et al.
Page
of 15